On the public citation graph

Metabolic stability and its role in the discovery of new chemical entities

https://doi.org/10.2478/acph-2019-0024

0 signed · 238 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/0471141755.ph0708s23openalex-snapshot

In Vitro Drug Metabolism Using Liver Microsomes

inferredcites →https://doi.org/10.1002/bdd.1889openalex-snapshot

Nonclinical pharmacokinetics and metabolism of EPZ‐5676, a novel DOT1L histone methyltransferase inhibitor

inferredcites →https://doi.org/10.1002/bdd.1897openalex-snapshot

Characterization of preclinicalin vitroandin vivoADME properties and prediction of human PK using a physiologically based pharmacokinetic model for YQA‐14, a new dopamine D3receptor antagonist candidate for treatment of drug addiction

inferredcites →https://doi.org/10.1002/bdd.1995openalex-snapshot

Metabolic profiling of a novel antithrombotic compound, S002‐333 and enantiomers: metabolic stability, species comparison andin vitro–in vivoextrapolation

inferredcites →https://doi.org/10.1002/cpph.9openalex-snapshot

In Vitro Drug Metabolism Using Liver Microsomes

inferredcites →https://doi.org/10.1002/dta.1662openalex-snapshot

High‐resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N‐(adamantan‐1‐yl)‐1‐(5‐fluoropentyl)‐1H‐indole‐3‐carboxamide (STS‐135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes

inferredcites →https://doi.org/10.1002/jbt.21826openalex-snapshot

In vitro mutagenic, antimutagenic, and antioxidant activities evaluation and biotransformation of some bioactive 4‐substituted 1‐(2‐methoxyphenyl)piperazine derivatives

inferredcites →https://doi.org/10.1002/jps.22179openalex-snapshot

Interstrain Differences of In Vitro Metabolic Stability and Impact on Early Drug Discovery

inferredcites →https://doi.org/10.1002/jps.22552openalex-snapshot

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance

inferredcites →https://doi.org/10.1002/jps.22792openalex-snapshot

In Vitro–In Vivo Extrapolation of Clearance: Modeling Hepatic Metabolic Clearance of Highly Bound Drugs and Comparative Assessment with Existing Calculation Methods

inferredcites →https://doi.org/10.1002/jps.23262openalex-snapshot

A comprehensive evaluation of metabolic activity and intrinsic clearance in suspensions and monolayer cultures of cryopreserved primary human hepatocytes

inferredcites →https://doi.org/10.1002/jps.23443openalex-snapshot

Presystemic Metabolism of AZ’0908, A Novel mPGES-1 Inhibitor: An In Vitro and In Vivo Cross-Species Comparison

inferredcites →https://doi.org/10.1002/med.1016openalex-snapshot

Role of drug metabolism in drug discovery and development

inferredcites →https://doi.org/10.1002/med.1017openalex-snapshot

Optimization of metabolic stability as a goal of modern drug design

inferredcites →https://doi.org/10.1002/prp2.44openalex-snapshot

Identification of metabolic pathways and enzyme systems involved in the in vitro human hepatic metabolism of dronedarone, a potent new oral antiarrhythmic drug

inferredcites →https://doi.org/10.1007/bf03191160openalex-snapshot

Exploratory population pharmacokinetics (e-PPK) analysis for predicting human PK using exploratory ADME data during early drug discovery research

inferredcites →https://doi.org/10.1007/s00280-011-1687-8openalex-snapshot

Pharmacokinetic characterization of a natural product–inspired novel MEK1 inhibitor E6201 in preclinical species

inferredcites →https://doi.org/10.1007/s11095-015-1800-5openalex-snapshot

Predicting Mouse Liver Microsomal Stability with “Pruned” Machine Learning Models and Public Data

inferredcites →https://doi.org/10.1007/s11419-015-0287-4openalex-snapshot

4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry

inferredcites →https://doi.org/10.1007/s13318-014-0229-2openalex-snapshot

Preclinical assessment of Orteronel®, a CYP17A1 enzyme inhibitor in rats

inferredcites →https://doi.org/10.1007/s40262-013-0089-yopenalex-snapshot

Differences in Cytochrome P450-Mediated Pharmacokinetics Between Chinese and Caucasian Populations Predicted by Mechanistic Physiologically Based Pharmacokinetic Modelling

inferredcites →https://doi.org/10.1016/0006-2952(94)90520-7openalex-snapshot

Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance

inferredcites →https://doi.org/10.1016/j.apsb.2012.10.004openalex-snapshot

Preclinical experimental models of drug metabolism and disposition in drug discovery and development

inferredcites →https://doi.org/10.1016/j.bcp.2008.07.003openalex-snapshot

In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes

inferredcites →https://doi.org/10.1016/j.bmc.2016.11.014openalex-snapshot

Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH3 or 2-CH3

inferredcites →https://doi.org/10.1016/j.cbi.2006.10.013openalex-snapshot

Hepatocytes—the choice to investigate drug metabolism and toxicity in man: In vitro variability as a reflection of in vivo

inferredcites →https://doi.org/10.1016/j.ddtec.2004.10.008openalex-snapshot

Metabolic screening in vitro: metabolic stability, CYP inhibition and induction

inferredcites →https://doi.org/10.1016/j.ddtec.2005.05.024openalex-snapshot

Preclinical in vitro screening assays for drug-like properties

inferredcites →https://doi.org/10.1016/j.ejps.2014.09.006openalex-snapshot

In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis

inferredcites →https://doi.org/10.1016/j.jchromb.2011.09.010openalex-snapshot

In vitro metabolic stability and metabolite profiling of TJ0711 hydrochloride, a newly developed vasodilatory β-blocker, using a liquid chromatography–tandem mass spectrometry method

inferredcites →https://doi.org/10.1016/j.jmb.2013.07.010openalex-snapshot

Advances in Molecular Modeling of Human Cytochrome P450 Polymorphism

inferredcites →https://doi.org/10.1016/j.neulet.2005.08.032openalex-snapshot

In vitro metabolic studies on the selective metabotropic glutamate receptor sub-type 5 (mGluR5) antagonist 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl]-pyridine (MTEP)

inferredcites →https://doi.org/10.1016/j.pharmthera.2012.12.007openalex-snapshot

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

inferredcites →https://doi.org/10.1016/s0022-3565(24)37073-9openalex-snapshot

Prediction of Species Differences (Rats, Dogs, Humans) in the In Vivo Metabolic Clearance of YM796 by the Liver from In Vitro Data

inferredcites →https://doi.org/10.1016/s0041-008x(03)00128-5openalex-snapshot

An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons

inferredcites →https://doi.org/10.1016/s0090-9556(24)14938-0openalex-snapshot

Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes

inferredcites →https://doi.org/10.1016/s0090-9556(25)08404-1openalex-snapshot

The importance of nonspecific binding in in vitro matrices, its impact on enzyme kinetic studies of drug metabolism reactions, and implications for in vitro-in vivo correlations.

inferredcites →https://doi.org/10.1016/s0163-7258(96)00184-2openalex-snapshot

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data

inferredcites →https://doi.org/10.1016/s0305-7372(98)90057-3openalex-snapshot

In-vitro metabolism of anti-cancer drugs, methods and applications: paclitaxel, docetaxel, tamoxifen and ifosfamide

inferredcites →https://doi.org/10.1016/s1359-6446(03)03019-8openalex-snapshot

Strategies for using in vitro screens in drug metabolism

inferredcites →https://doi.org/10.1016/s1359-6446(04)03280-5openalex-snapshot

Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability

inferredcites →https://doi.org/10.1021/acschemneuro.6b00432openalex-snapshot

3-Aminomethyl Derivatives of 2-Phenylimidazo[1,2-a]-pyridine as Positive Allosteric Modulators of GABAA Receptor with Potential Antipsychotic Activity

inferredcites →https://doi.org/10.1021/jm901207nopenalex-snapshot

Synthesis and Structure−Activity Studies of Biphenyl Analogues of the Tuberculosis Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)

inferredcites →https://doi.org/10.1023/a:1018943613122openalex-snapshot

Physiological Parameters in Laboratory Animals and Humans

inferredcites →https://doi.org/10.1023/b:pham.0000026429.12114.7dopenalex-snapshot

Comparison of the Use of Liver Models for Predicting Drug Clearance Using in Vitro Kinetic Data from Hepatic Microsomes and Isolated Hepatocytes

inferredcites →https://doi.org/10.1038/nrd1470openalex-snapshot

Can the pharmaceutical industry reduce attrition rates?

inferredcites →https://doi.org/10.1038/srep17671openalex-snapshot

Content and activity of human liver microsomal protein and prediction of individual hepatic clearance in vivo

inferredcites →https://doi.org/10.1080/0049825031000076177openalex-snapshot

Prediction of in vivo hepatic clearance from in vitro data using cryopreserved human hepatocytes

inferredcites →https://doi.org/10.1080/00498250802446286openalex-snapshot

Reliability of human cryopreserved hepatocytes and liver microsomes asin vitrosystems to predict metabolic clearance

inferredcites →https://doi.org/10.1089/adt.2007.103openalex-snapshot

An Automated Liquid Chromatography-Mass Spectrometry Process to Determine Metabolic Stability Half-Life and Intrinsic Clearance of Drug Candidates by Substrate Depletion

inferredcites →https://doi.org/10.1111/cbdd.12842openalex-snapshot

Design, synthesis, and anticonvulsant activity of some derivatives of xanthone with aminoalkanol moieties

inferredcites →https://doi.org/10.1111/j.1472-8206.1999.tb00364.xopenalex-snapshot

Interspecies variability and drug interactions of clozapine metabolism by microsomes

inferredcites →https://doi.org/10.1111/j.1742-7843.2005.pto960305.xopenalex-snapshot

Prediction of Drug Metabolism and Interactions on the Basis of in vitro Investigations

inferredcites →https://doi.org/10.1124/dmd.104.000026openalex-snapshot

EVALUATION OF FRESH AND CRYOPRESERVED HEPATOCYTES AS IN VITRO DRUG METABOLISM TOOLS FOR THE PREDICTION OF METABOLIC CLEARANCE

inferredcites →https://doi.org/10.1124/dmd.105.004259openalex-snapshot

A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES

inferredcites →https://doi.org/10.1124/dmd.106.010793openalex-snapshot

Comparison of Intrinsic Clearance in Liver Microsomes and Hepatocytes from Rats and Humans: Evaluation of Free Fraction and Uptake in Hepatocytes

inferredcites →https://doi.org/10.1124/dmd.106.011569openalex-snapshot

Evaluation of Cryopreserved Human Hepatocytes as an Alternative in Vitro System to Microsomes for the Prediction of Metabolic Clearance

inferredcites →https://doi.org/10.1124/dmd.106.012781openalex-snapshot

Reduction of Site-Specific CYP3A-Mediated Metabolism for Dual Angiotensin and Endothelin Receptor Antagonists in Various in Vitro Systems and in Cynomolgus Monkeys

inferredcites →https://doi.org/10.1124/dmd.107.018424openalex-snapshot

Metabolism of Boswellic Acids in Vitro and in Vivo

inferredcites →https://doi.org/10.1124/dmd.108.024810openalex-snapshot

Evaluation of Recombinant Cytochrome P450 Enzymes as an in Vitro System for Metabolic Clearance Predictions

inferredcites →https://doi.org/10.1124/dmd.110.034348openalex-snapshot

Drug Metabolism and Pharmacokinetics of 4-Substituted Methoxybenzoyl-aryl-thiazoles

inferredcites →https://doi.org/10.1124/dmd.110.036673openalex-snapshot

Biotransformation of a Novel Antimitotic Agent, I-387, by Mouse, Rat, Dog, Monkey, and Human Liver Microsomes and In Vivo Pharmacokinetics in Mice

inferredcites →https://doi.org/10.1124/dmd.110.037234openalex-snapshot

Preclinical and Clinical Pharmacokinetics of PF-02413873, a Nonsteroidal Progesterone Receptor Antagonist

inferredcites →https://doi.org/10.1124/dmd.111.042309openalex-snapshot

Comparison of Cryopreserved HepaRG Cells with Cryopreserved Human Hepatocytes for Prediction of Clearance for 26 Drugs

inferredcites →https://doi.org/10.1124/dmd.113.053397openalex-snapshot

Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac

inferredcites →https://doi.org/10.1124/dmd.116.072017openalex-snapshot

An Automated High-Throughput Metabolic Stability Assay Using an Integrated High-Resolution Accurate Mass Method and Automated Data Analysis Software

inferredcites →https://doi.org/10.1128/aac.02068-16openalex-snapshot

Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis

inferredcites →https://doi.org/10.1155/2015/857327openalex-snapshot

How to Choose In Vitro Systems to Predict In Vivo Drug Clearance: A System Pharmacology Perspective

inferredcites →https://doi.org/10.1177/1087057103255988openalex-snapshot

Optimization of a Higher Throughput Microsomal Stability Screening Assay for Profiling Drug Discovery Candidates

inferredcites →https://doi.org/10.1208/s12248-009-9103-6openalex-snapshot

Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development

inferredcites →https://doi.org/10.1208/s12248-014-9691-7openalex-snapshot

Addressing the Challenges of Low Clearance in Drug Research

inferredcites →https://doi.org/10.1211/jpp.59.6.0007openalex-snapshot

Prediction of human pharmacokinetics—evaluation of methods for prediction of hepatic metabolic clearance

inferredcites →https://doi.org/10.1248/bpb.30.1021openalex-snapshot

In Vitro Phase I Cytochrome P450 Metabolism, Permeability and Pharmacokinetics of SB639, a Novel Histone Deacetylase Inhibitor in Preclinical Species

inferredcites →https://doi.org/10.1371/journal.pone.0094962openalex-snapshot

In Vitro Metabolism of 20(R)-25-Methoxyl-Dammarane-3, 12, 20-Triol from Panax notoginseng in Human, Monkey, Dog, Rat, and Mouse Liver Microsomes

inferredcites →https://doi.org/10.1371/journal.pone.0162162openalex-snapshot

Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy

inferredcites →https://doi.org/10.14573/altex.2009.3.214openalex-snapshot

Comparison of metabolic stability and metabolite identification of 55 ECVAM/ICCVAM validation compounds between human and rat liver homogenates and microsomes - a preliminary analysis

inferredcites →https://doi.org/10.1517/17425250903405622openalex-snapshot

Use of intrinsic clearance for prediction of human hepatic clearance

inferredcites →https://doi.org/10.1517/17425255.1.1.49openalex-snapshot

In vitroscreening of drug metabolism during drug development: can we trust the predictions?

inferredcites →https://doi.org/10.1517/17425255.4.7.871openalex-snapshot

Species selection considerations for preclinical toxicology studies for biotherapeutics

inferredcites →https://doi.org/10.2147/dddt.s83055openalex-snapshot

Characterization of preclinical in vitro and in vivo pharmacokinetics properties for KBP-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis

inferredcites →https://doi.org/10.2165/00003088-200342020-00004openalex-snapshot

Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism

inferredcites →https://doi.org/10.2165/00003088-200342060-00002openalex-snapshot

Metabolic Stability for Drug Discovery and Development

inferredcites →https://doi.org/10.2174/1386207013331101openalex-snapshot

In Vitro High Throughput Screening of Compounds for Favorable Metabolic Properties in Drug Discovery.

inferredcites →https://doi.org/10.2174/138620710790596790openalex-snapshot

Scaling In Vivo Pharmacokinetics from In Vitro Metabolic Stability Data in Drug Discovery

inferredcites →https://doi.org/10.2174/1389200003339018openalex-snapshot

Early ADME in Support of Drug Discovery: The Role of Metabolic Stability Studies

inferredcites →https://doi.org/10.2174/1389200003339117openalex-snapshot

Drug-Metabolizing Enzymes Mechanisms and Functions

inferredcites →https://doi.org/10.2174/1389200043335414openalex-snapshot

Human Hepatocytes in Primary Culture: The Choice to Investigate Drug Metabolism in Man

inferredcites →https://doi.org/10.2174/138920006775541552openalex-snapshot

Preclinical Pharmacokinetics: An Approach Towards Safer and Efficacious Drugs

inferredcites →https://doi.org/10.2174/138920006777697891openalex-snapshot

Application of Mass Spectrometry for Metabolite Identification

inferredcites →https://doi.org/10.2174/138920007779315053openalex-snapshot

Scaling Factors for the Extrapolation of In Vivo Metabolic Drug Clearance From In Vitro Data: Reaching a Consensus on Values of Human Micro-somal Protein and Hepatocellularity Per Gram of Liver

inferredcites →https://doi.org/10.2174/138920007782798207openalex-snapshot

The Conduct of Drug Metabolism Studies Considered Good Practice (II): In Vitro Experiments

inferredcites →https://doi.org/10.2174/138920008786485146openalex-snapshot

Metabolic Stability: Main Enzymes Involved and Best Tools To Assess It

inferredcites →https://doi.org/10.2174/138920008786485164openalex-snapshot

Methods for Predicting In Vivo Pharmacokinetics Using Data from In Vitro Assays

inferredcites →https://doi.org/10.2174/138920010792927334openalex-snapshot

Impact of Input Parameters on the Prediction of Hepatic Plasma Clearance Using the Well-Stirred Model

inferredcites →https://doi.org/10.2174/138955709788452694openalex-snapshot

Advances in the Integration of Drug Metabolism into the Lead Optimization Paradigm

inferredcites →https://doi.org/10.2174/1568026614666140506114411openalex-snapshot

In Vitro Human Hepatocyte-Based Experimental Systems for the Evaluation of Human Drug Metabolism, Drug-Drug Interactions, and Drug Toxicity in Drug Development

inferredcites →https://doi.org/10.2174/157016310793180576openalex-snapshot

Hepatocytes as a Tool in Drug Metabolism, Transport and Safety Evaluations in Drug Discovery

inferredcites →https://doi.org/10.4172/2157-7609.1000126openalex-snapshot

Comparative in-vitro Intrinsic Clearance of Imipramine in Multiple Species Liver Microsomes: Human, Rat, Mouse and Dog

inferredcites →https://doi.org/10.4172/2157-7609.1000173openalex-snapshot

Species Differences in the Pharmacokinetic Parameters of Cytochrome P450 Probe Substrates between Experimental Animals, such as Mice, Rats, Dogs, Monkeys, and Microminipigs, and Humans

inferredcites →https://doi.org/10.4172/2329-6798.1000129openalex-snapshot

In vitro Metabolic Stability Study of New Cyclen Based Antimalarial Drug Leads Using RP-HPLC and LC-MS/MS

inferredcites →https://doi.org/10.4236/health.2009.14041openalex-snapshot

Characterization of in vitro and in vivo metabolism of AG-024322, a novel cyclin-dependent kinase (CDK)

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4778126openalex-extracted

inferred← citeshttps://doi.org/10.1002/ardp.70111openalex-snapshot

Ultra‐Fast Green UPLC‐MS/MS Method for the Quantification of Cediranib in the Human Liver Microsome Matrix: In Vitro and In Silico Metabolic Stability Assessment

inferred← citeshttps://doi.org/10.1002/ardp.70130openalex-snapshot

Ultra‐Fast UPLC‐MS/MS Method for the Ripretinib Quantification in the HLMs Matrix With Metabolic Stability Assessment: In‐Silico Study for Toxic Alerts and the Metabolic Lability

inferred← citeshttps://doi.org/10.1002/ardp.70331openalex-snapshot

An Ultra‐Fast UPLC‐MS/MS Method for Quantifying Ivosidenib: Application to Assessment of Metabolic Stability in Human Liver Microsomes

inferred← citeshttps://doi.org/10.1002/bmc.5618openalex-snapshot

Assessment of metabolic stability and pharmacokinetics by LC–MS/MS and establishment of the safe dose of IMID‐2, a novel anticancer molecule under drug discovery

inferred← citeshttps://doi.org/10.1002/bmc.70231openalex-snapshot

Evaluation of Anlotinib Metabolic Stability in HLMs Matrix Applying Ultra‐Fast UPLC–MS/MS Approach: Greenness Assessment With In Silico Testing for Structural Alarms Related to the Metabolic Lability and DEREK Toxicity

inferred← citeshttps://doi.org/10.1002/chem.202002856openalex-snapshot

Multidisciplinary Preclinical Investigations on Three Oxamniquine Analogues as New Drug Candidates for Schistosomiasis**

inferred← citeshttps://doi.org/10.1002/jssc.202400346openalex-snapshot

An ultra‐fast ultra‐high‐performance liquid chromatography‐tandem mass spectrometry method for estimating the in vitro metabolic stability of palbociclib in human liver microsomes: In silico study for metabolic lability, absorption, distribution, metabolism, and excretion features, and DEREK…

inferred← citeshttps://doi.org/10.1002/jssc.202400393openalex-snapshot

An ultra‐fast green ultra‐high‐performance liquid chromatography‐tandem mass spectrometry method for estimating the in vitro metabolic stability of zotizalkib in human liver microsomes

inferred← citeshttps://doi.org/10.1002/prp2.70037openalex-snapshot

In Vitro Hepatic Metabolism Input Parameters Support Toxicokinetic Simulations for the Formation of Methoxy Propionic Acid From β‐Isomer Propylene Glycol Methyl Ether

inferred← citeshttps://doi.org/10.1007/s00204-026-04552-3openalex-snapshot

Toxicokinetics and analytical toxicology of four N, N-dimethyltryptamine derivatives studied in human in vitro systems and in vivo by means of zebrafish embryos

inferred← citeshttps://doi.org/10.1007/s11419-020-00540-zopenalex-snapshot

In vitro and in vivo studies of triacetone triperoxide (TATP) metabolism in humans

inferred← citeshttps://doi.org/10.1007/s13318-024-00895-3openalex-snapshot

Uridine 5′-Diphospho-glucuronosyltransferase 1A3 (UGT1A3) Prediction of Hepatic Clearance of Organic Anion Transporting Polypeptide 1B3 (OATP1B3) Substrate Telmisartan by Glucuronidation Using In Vitro–In Vivo Extrapolation (IVIVE)

inferred← citeshttps://doi.org/10.1007/s13318-024-00931-2openalex-snapshot

Determination of Intrinsic Clearance and Fraction Unbound in Human Liver Microsomes and In Vitro-In Vivo Extrapolation of Human Hepatic Clearance for Marketed Central Nervous System Drugs

inferred← citeshttps://doi.org/10.1007/s43440-024-00686-2openalex-snapshot

Advanced pharmacological and pharmacokinetic evaluation of 1,3 dimethylpurine-2,6-dione derivative (GR-14) with prominent mood-modulating activity in rats

inferred← citeshttps://doi.org/10.1016/j.actatropica.2020.105801openalex-snapshot

3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice

inferred← citeshttps://doi.org/10.1016/j.bcp.2025.117564openalex-snapshot

Assessing the hepatic metabolism of six sunscreen ultraviolet filters: In vitro–in vivo extrapolation approach using human liver microsomes and hepatic parameter predictions for exposure risk assessment

inferred← citeshttps://doi.org/10.1016/j.bioorg.2025.109190openalex-snapshot

Modifications of NU-9, a potent protein aggregation inhibitor. Properties and activity in a cellular model of amyotrophic lateral sclerosis

inferred← citeshttps://doi.org/10.1016/j.bmc.2022.116994openalex-snapshot

Ligand- and structure-based identification of novel CDK9 inhibitors for the potential treatment of leukemia

inferred← citeshttps://doi.org/10.1016/j.bmc.2025.118196openalex-snapshot

Scaffold hopping and sidechain modification from a flavone scaffold lead to discovery of potent, selective CK2A2 inhibitors with favorable properties for CNS activity

inferred← citeshttps://doi.org/10.1016/j.cbs.2026.100013openalex-snapshot

Metabolic Stability In Hepatocellular Carcinoma Drug Design: Current Challenges And Optimization Strategies

inferred← citeshttps://doi.org/10.1016/j.comtox.2024.100334openalex-snapshot

Species specific kinetics of imidacloprid and carbendazim in mouse and rat and consequences for biomonitoring

inferred← citeshttps://doi.org/10.1016/j.drudis.2026.104655openalex-snapshot

Foundation models and AI agents in oncology drug discovery

inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115112openalex-snapshot

New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer

inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115329openalex-snapshot

Dimeric 2-aminoimidazoles are highly active adjuvants for gram-positive selective antibiotics against Acinetobacter baumannii

inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115583openalex-snapshot

Discovery of tetrasubstituted thiophenes as Cisd2 activators: A potential novel therapeutic option in nonalcoholic fatty liver disease

inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116465openalex-snapshot

Antiviral drug discovery: Pyrimidine entry inhibitors for Zika and dengue viruses

inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116823openalex-snapshot

Improved N-phenylpyrrolamide inhibitors of DNA gyrase as antibacterial agents for high-priority bacterial strains

inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.117616openalex-snapshot

Discovery of a deuterated TNF-α small molecule modulator for potential treatment of ulcerative colitis

inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.117678openalex-snapshot

Novel tacrine-based multi-target directed Ligands: Enhancing cholinesterase inhibition, NMDA receptor antagonism, and CNS bioavailability for Alzheimer's disease treatment

inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.117936openalex-snapshot

Targeting voltage-gated proton channel HV1: Optimised 5-phenyl-2-aminoimidazoles with anticancer potential

inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.118268openalex-snapshot

Synthesis and biological evaluation of novel C-30 modified lupane triterpenoids selectively cytotoxic against cancer cells

inferred← citeshttps://doi.org/10.1016/j.ejmech.2026.118996openalex-snapshot

Prediction of intrinsic clearance using an explainable learning framework integrating molecular fingerprints and graph representation

inferred← citeshttps://doi.org/10.1016/j.ejps.2025.107397openalex-snapshot

Synthesis, in vitro characterization and biopharmaceutical evaluation of a novel phosphate prodrug of sorafenib

inferred← citeshttps://doi.org/10.1016/j.etap.2025.104795openalex-snapshot

In vitro and in vivo evaluation of propylene glycol ethers metabolism in humans

inferred← citeshttps://doi.org/10.1016/j.fct.2025.115761openalex-snapshot

Metabolite identification of ripretinib by UPLC-ESI-MS/MS: in silico prediction, in vitro metabolism, and stability assessment

inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e34109openalex-snapshot

Characterization of the in vitro metabolic profile of nazartinib in HLMs using UPLC-MS/MS method: In silico metabolic lability and DEREK structural alerts screening using StarDrop software

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.143236openalex-snapshot

Hyaluronate-incorporated edaravone nanostructured lipid carriers for nose-to-brain targeting- biphasic DoE optimization, pharmacokinetic, and brain distribution studies

inferred← citeshttps://doi.org/10.1016/j.jpba.2025.116957openalex-snapshot

Enantioselective in vitro metabolism of the fungicide penconazole by human liver microsomes and in vitro–in vivo extrapolation of hepatic clearance

inferred← citeshttps://doi.org/10.1016/j.microc.2020.105550openalex-snapshot

The influence of phase II enzymes on in vitro half-life of pirydo[1,2-c]pirymidine derivatives as structural analogues of arylpiperazine

inferred← citeshttps://doi.org/10.1016/j.microc.2025.114306openalex-snapshot

DLLME and LC-MS for stereoselective hydrolysis of acephate and methamidophos in human liver microsomes: Enzyme characterization and in vitro-in vivo extrapolation

inferred← citeshttps://doi.org/10.1016/j.rechem.2026.103305openalex-snapshot

Assessing the impact of data harmonization on human liver microsomal stability prediction model performance

inferred← citeshttps://doi.org/10.1016/j.taap.2022.116318openalex-snapshot

In silico and in vitro ADME-Tox analysis and in vivo pharmacokinetic study of representative pan-PDE inhibitors from the group of 7,8-disubstituted derivatives of 1,3-dimethyl-7H-purine-2,6-dione

inferred← citeshttps://doi.org/10.1016/j.tox.2025.154081openalex-snapshot

Hepatic and extra-hepatic metabolism of propylene glycol ethers in the context of central nervous system toxicity

inferred← citeshttps://doi.org/10.1016/j.vascn.2024.107540openalex-snapshot

Ultra-fast UPLC–MS/MS approach for estimating X-376 in human liver microsomes: Evaluation of metabolic stability via in silico software and in vitro analysis

inferred← citeshttps://doi.org/10.1021/acs.jcim.2c00318openalex-snapshot

Predicting Total Drug Clearance and Volumes of Distribution Using the Machine Learning-Mediated Multimodal Method through the Imputation of Various Nonclinical Data

inferred← citeshttps://doi.org/10.1021/acs.jcim.4c00159openalex-snapshot

Enhancing Multi-species Liver Microsomal Stability Prediction through Artificial Intelligence

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c00528openalex-snapshot

Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c00816openalex-snapshot

Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c02150openalex-snapshot

Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00098openalex-snapshot

Development of Predictive Classification Models for Whole Cell Antimycobacterial Activity of Benzothiazinones

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c00831openalex-snapshot

Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c00377openalex-snapshot

Structure-Based Discovery Targeting GSK-3α Reveals Potent Nanomolar Selective 4-Phenyl-1H-benzofuro[3,2-b]pyrazolo[4,3-e]pyridine Inhibitor with Promising Glioblastoma and CNS-Active Potential in Cellular Models

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c02788openalex-snapshot

Multiparameter Optimization of Pseudomonas aeruginosa Elastase Inhibitors for Systemic Administration

inferred← citeshttps://doi.org/10.1021/acsinfecdis.1c00394openalex-snapshot

Oral Efficacy of a Diselenide Compound Loaded in Nanostructured Lipid Carriers in a Murine Model of Visceral Leishmaniasis

inferred← citeshttps://doi.org/10.1021/acsmedchemlett.4c00530openalex-snapshot

Protection against Amyloid-β Aggregation and Ferroptosis/Oxytosis Toxicity by Arylpyrazolones: Alzheimer’s Disease Therapeutics

inferred← citeshttps://doi.org/10.1021/acsomega.2c07089openalex-snapshot

Comprehensive Profiling of Mangiferin Metabolites In Vivo and In Vitro Based on the “Drug Metabolite Clusters” Analytical Strategy

inferred← citeshttps://doi.org/10.1021/acsptsci.1c00021openalex-snapshot

Macrocyclic Gq Protein Inhibitors FR900359 and/or YM-254890–Fit for Translation?

inferred← citeshttps://doi.org/10.1021/acsptsci.5c00683openalex-snapshot

Synthesis, Biological Evaluation, and Computational Study of Pyridine- and Indazole-Based Inhibitors of the Inducible Nitric Oxide Synthase as Promising Antipsoriatic Agents

inferred← citeshttps://doi.org/10.1038/s41598-020-77327-0openalex-snapshot

Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models

inferred← citeshttps://doi.org/10.1039/d4dt01191kopenalex-snapshot

Exploring the potential of ruthenium( ii )–phosphine–mercapto complexes as new anticancer agents

inferred← citeshttps://doi.org/10.1039/d5an01036eopenalex-snapshot

Development and validation of a quick and sensitive UPLC-MS/MS method for measuring ensartinib in HLMs: investigation of structural alerts associated with metabolic lability and in silico toxicity

inferred← citeshttps://doi.org/10.1039/d5an01132aopenalex-snapshot

Determination of veliparib metabolic stability in the human liver microsomes using a hydrophilic interaction UPLC-MS/MS quantitative method: greenness assessment with an in silico study for ADME, DEREK alarms and metabolic lability

inferred← citeshttps://doi.org/10.1039/d5an01155hopenalex-snapshot

Quantification of buparlisib in human liver microsomes employing an ultra-fast, sensitive UPLC-MS/MS method: in vitro and in silico metabolic stability evaluation

inferred← citeshttps://doi.org/10.1039/d5ay00294jopenalex-snapshot

An ultra-fast UPLC-MS/MS approach for the quantification of baricitinib in the HLM matrix: greenness assessment with application to in vitro and in silico metabolic stability studies

inferred← citeshttps://doi.org/10.1039/d5ay00513bopenalex-snapshot

Validated green ultra-fast UPLC-MS/MS method for the quantification of fedratinib in an HLM matrix: application to in vitro and in silico metabolic stability studies

inferred← citeshttps://doi.org/10.1039/d5ay01035gopenalex-snapshot

Assessment of the metabolic stability of avapritinib in human liver microsomes using a fast and green UPLC-MS/MS method: screening for structural alarms associated with metabolic lability and in silico toxicity

inferred← citeshttps://doi.org/10.1039/d5ay01676bopenalex-snapshot

Estimation of the metabolic stability of omipalisib in human liver microsomes employing an ultra-fast UPLC-MS/MS approach: in silico screening for structural alarms and metabolic lability

inferred← citeshttps://doi.org/10.1039/d5ay01691fopenalex-snapshot

Developing and validating a sensitive and fast UPLC-MS/MS method for estimating the in vitro metabolic stability of crenolanib in HLMs: identification of structural alarms related to the in silico toxicity and metabolic lability

inferred← citeshttps://doi.org/10.1039/d5ay02096dopenalex-snapshot

A hydrophilic interaction UPLC-MS/MS quantitative method for the quantification of saracatinib in the human liver microsome matrix and its application in in vitro metabolic stability assessment

inferred← citeshttps://doi.org/10.1039/d6an00077kopenalex-snapshot

Quantification of olaparib in human liver microsomes using an ultra-fast UPLC-MS/MS quantitative approach: in vitro and in silico metabolic stability assessment

inferred← citeshttps://doi.org/10.1039/d6an00200eopenalex-snapshot

Evaluation of vardenafil's metabolic stability in human liver microsomes through ultra-fast UPLC-MS/MS for quantitative analysis, including assessments of greenness, ADME properties, DEREK alerts, and metabolic lability

inferred← citeshttps://doi.org/10.1039/d6ay01110aopenalex-snapshot

Quantification of tadalafil in HLMs using an ultrafast UPLC-MS/MS method to assess metabolic stability, including in silico analysis of metabolic lability, DEREK alerts, and ADME characteristics

inferred← citeshttps://doi.org/10.1080/00498254.2021.1874563openalex-snapshot

In vitro metabolism of HMTD and blood stability and toxicity of peroxide explosives (TATP and HMTD) in canines and humans

inferred← citeshttps://doi.org/10.1080/00498254.2023.2289635openalex-snapshot

Metabolite characterisation of the peptide–drug conjugate LN005 in liver S9s by UHPLC-Orbitrap-HRMS

inferred← citeshttps://doi.org/10.1080/14756366.2024.2431832openalex-snapshot

Evaluation of hydrazone and N -acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde as potential drugs against Alzheimer’s disease

inferred← citeshttps://doi.org/10.1080/17425247.2025.2578384openalex-snapshot

Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part I: receptor-mediated nose-to-brain delivery approaches for glioblastoma

inferred← citeshttps://doi.org/10.1089/adt.2020.970openalex-snapshot

A Fully Integrated Assay Panel for Early Drug Metabolism and Pharmacokinetics Profiling

inferred← citeshttps://doi.org/10.1093/bioinformatics/btab547openalex-snapshot

PredMS: a random forest model for predicting metabolic stability of drug candidates in human liver microsomes

inferred← citeshttps://doi.org/10.1093/bioinformatics/btad503openalex-snapshot

CMMS-GCL: cross-modality metabolic stability prediction with graph contrastive learning

inferred← citeshttps://doi.org/10.1093/bioinformatics/btaf524openalex-snapshot

HyperPhS: a pharmacophore-guided multimodal representation framework for metabolic stability prediction through contrastive hypergraph learning

inferred← citeshttps://doi.org/10.1101/2025.08.21.671656openalex-snapshot

Moremi Bio Agent: Leveraging Agentic Large Language Model for the Discovery of Broad-Spectrum Antibiotics for Enterobacteriaceae

inferred← citeshttps://doi.org/10.1111/fcp.12914openalex-snapshot

Rapid high performance liquid chromatography method for erlotinib quantification in vitro: Application to study the effect of resveratrol on metabolism and cellular uptake of erlotinib

inferred← citeshttps://doi.org/10.1128/aac.01127-23openalex-snapshot

Effect of the aggregated protein dye YAT2150 on Leishmania parasite viability

inferred← citeshttps://doi.org/10.1134/s1990750821040089openalex-snapshot

Prediction of Metabolic Stability of Xenobiotics by the Pass and Gusar Programs

inferred← citeshttps://doi.org/10.1155/ianc/9508534openalex-snapshot

An Ultrafast UPLC‐MS/MS Approach for Determining the In Vitro Metabolic Stability of Duvelisib in the HLMs: In Silico Screening for Metabolic Lability, ADME Features, and DEREK Alerts

inferred← citeshttps://doi.org/10.1556/1326.2024.01290openalex-snapshot

An ultra-fast validated green UPLC-MS/MS approach for the evaluation of zanubrutinib in vitro metabolic stability in human liver microsomes: Screening for in silico metabolic lability, ADME parameters, and DEREK toxic alerts

inferred← citeshttps://doi.org/10.1556/1326.2024.01300openalex-snapshot

An ultra-fast validated green UPLC-MS/MS method for the quantification of osimertinib in human liver microsomes: Screening for ADME parameters and in vitro metabolic stability

inferred← citeshttps://doi.org/10.1556/1326.2025.01282openalex-snapshot

Ultra-fast eco-friendly UHPLC–MS/MS methodology for the quantification of ASP3026 in human liver microsomes: Evaluation of metabolic stability via in silico software and in vitro metabolic incubation

inferred← citeshttps://doi.org/10.1556/1326.2025.01339openalex-snapshot

Validated and green UPLC-MS/MS method for belumosudil quantification in human liver microsomes: Application to in vitro metabolic stability assessment

inferred← citeshttps://doi.org/10.18097/pbmc20216703295openalex-snapshot

Predict of metabolic stability of xenobiotics by the PASS and GUSAR programs

inferred← citeshttps://doi.org/10.2147/dddt.s379496openalex-snapshot

Recent Updates on the Development of Deuterium-Containing Drugs for the Treatment of Cancer

inferred← citeshttps://doi.org/10.2174/0115734099370189250416024026openalex-snapshot

In Silico Identification of 2,4-Diaryl-6-styrylpyridine Derivatives as Orthosteric-allosteric EGFR Inhibitors

inferred← citeshttps://doi.org/10.2174/1389200223666220628095616openalex-snapshot

The Development of a Physiologically Based Pharmacokinetic (PBPK) Model of Andrographolide in Mice and Scaling it up to Rats, Dogs, and Humans

inferred← citeshttps://doi.org/10.23860/gonsalves-michelle-2020openalex-snapshot

MAKING ENERGETIC MATERIALS SAFER

inferred← citeshttps://doi.org/10.26434/chemrxiv.12102894openalex-snapshot

Multidisciplinary Preclinical Investigations on Three Oxamniquine Analogues as Novel Treatment Options for Schistosomiasis

inferred← citeshttps://doi.org/10.3389/fchem.2024.1323738openalex-snapshot

Assessment of the in vitro metabolic stability of CEP-37440, a selective FAK/ALK inhibitor, in HLMs using fast UPLC–MS/MS method: in silico metabolic lability and DEREK alerts screening

inferred← citeshttps://doi.org/10.3389/fonc.2023.1293728openalex-snapshot

Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer

inferred← citeshttps://doi.org/10.3389/fphar.2020.577998openalex-snapshot

In Vitro Hepatic Metabolism of Curcumin Diethyl Disuccinate by Liver S9 from Different Animal Species

inferred← citeshttps://doi.org/10.3389/fphar.2023.1145140openalex-snapshot

Metabolic stability and metabolite profiling of emerging synthetic cathinones

inferred← citeshttps://doi.org/10.3390/ecb2021-10259openalex-snapshot

Optimization of Pharmacokinetic Compound Profile of Ligands of Serotonin Receptor 5-HT7–Application of Machine Learning Methods in Ligand- and Structure-Based Approach

inferred← citeshttps://doi.org/10.3390/ijms21124372openalex-snapshot

S(+)-(2E)-N-(2-Hydroxypropyl)-3-Phenylprop-2-Enamide (KM-568): A Novel Cinnamamide Derivative with Anticonvulsant Activity in Animal Models of Seizures and Epilepsy

inferred← citeshttps://doi.org/10.3390/ijms23073635openalex-snapshot

A Pharmacokinetic and Metabolism Study of the TRPC6 Inhibitor SH045 in Mice by LC-MS/MS

inferred← citeshttps://doi.org/10.3390/ijms241813707openalex-snapshot

Anti-Inflammatory Activities of 8-Benzylaminoxanthines Showing High Adenosine A2A and Dual A1/A2A Receptor Affinity

inferred← citeshttps://doi.org/10.3390/ijms242216331openalex-snapshot

Naphthyl-Substituted Indole and Pyrrole Carboxylic Acids as Effective Antibiotic Potentiators—Inhibitors of Bacterial Cystathionine γ-Lyase

inferred← citeshttps://doi.org/10.3390/medicina60101626openalex-snapshot

An Ultra-Fast Green UHPLC-MS/MS Method for Assessing the In Vitro Metabolic Stability of Dovitinib: In Silico Study for Absorption, Distribution, Metabolism, Excretion, Metabolic Lability, and DEREK Alerts

inferred← citeshttps://doi.org/10.3390/medicina60121914openalex-snapshot

An Ultra-Fast Validated Green UPLC-MS/MS Approach for Assessing Revumenib in Human Liver Microsomes: In Vitro Absorption, Distribution, Metabolism, and Excretion and Metabolic Stability Evaluation

inferred← citeshttps://doi.org/10.3390/metabo12080752openalex-snapshot

Metabolite Identification of HIV-1 Capsid Modulators PF74 and 11L in Human Liver Microsomes

inferred← citeshttps://doi.org/10.3390/metabo14080425openalex-snapshot

The Comparative Metabolism of a Novel Hepatocellular Carcinoma Therapeutic Agent, 2,3-Diamino-N-(4-(benzo[d]thiazol-2-yl)phenyl)propanamide, in Human and Animal Hepatocytes

inferred← citeshttps://doi.org/10.3390/molecules26123542openalex-snapshot

Pharmacokinetics-Driven Evaluation of the Antioxidant Activity of Curcuminoids and Their Major Reduced Metabolites—A Medicinal Chemistry Approach

inferred← citeshttps://doi.org/10.3390/molecules27061850openalex-snapshot

Evaluation of Two Novel Hydantoin Derivatives Using Reconstructed Human Skin Model EpiskinTM: Perspectives for Application as Potential Sunscreen Agents

inferred← citeshttps://doi.org/10.3390/molecules27092854openalex-snapshot

Metabolite Identification of a Novel Anti-Leishmanial Agent OJT007 in Rat Liver Microsomes Using LC-MS/MS

inferred← citeshttps://doi.org/10.3390/molecules28052322openalex-snapshot

Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation

inferred← citeshttps://doi.org/10.3390/molecules28062618openalex-snapshot

Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method

inferred← citeshttps://doi.org/10.3390/molecules28207220openalex-snapshot

An Ultrafast UPLC–MS/MS Method for Characterizing the In Vitro Metabolic Stability of Acalabrutinib

inferred← citeshttps://doi.org/10.3390/molecules31071109openalex-snapshot

Biphenyl as a Privileged Structure in Medicinal Chemistry: Advances in Anti-Infective Drug Discovery

inferred← citeshttps://doi.org/10.3390/pathogens12101242openalex-snapshot

Novel Baicalein-Derived Inhibitors of Plasmodium falciparum

inferred← citeshttps://doi.org/10.3390/ph14030208openalex-snapshot

Tryptophanol-Derived Oxazolopyrrolidone Lactams as Potential Anticancer Agents against Gastric Adenocarcinoma

inferred← citeshttps://doi.org/10.3390/ph14080744openalex-snapshot

Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT1A and D2 Receptors

inferred← citeshttps://doi.org/10.3390/ph16020146openalex-snapshot

Metabolism-Guided Optimization of Tryptophanol-Derived Isoindolinone p53 Activators

inferred← citeshttps://doi.org/10.3390/ph16121639openalex-snapshot

A Review on Molecular Docking on HDAC Isoforms: Novel Tool for Designing Selective Inhibitors

inferred← citeshttps://doi.org/10.3390/ph18030424openalex-snapshot

The Importance of Murine Models in Determining In Vivo Pharmacokinetics, Safety, and Efficacy in Antimalarial Drug Discovery

inferred← citeshttps://doi.org/10.3390/pharmaceutics15041095openalex-snapshot

In Silico Analyses of a Promising Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis Targeting Superoxide Dismutase I Protein

inferred← citeshttps://doi.org/10.3390/pharmaceutics15102449openalex-snapshot

Evaluation of Alectinib Metabolic Stability in HLMs Using Fast LC-MS/MS Method: In Silico ADME Profile, P450 Metabolic Lability, and Toxic Alerts Screening

inferred← citeshttps://doi.org/10.3390/pharmaceutics18010114openalex-snapshot

Metabolism of the Isoflavone Derivative Structural Isomers ACF-02 and ACF-03 in Human Liver Microsomes

inferred← citeshttps://doi.org/10.3390/separations10040247openalex-snapshot

A Rapid and Sensitive UPLC-MS/MS Method for Quantifying Capmatinib in Human Liver Microsomes: Evaluation of Metabolic Stability by In Silico and In Vitro Analysis

inferred← citeshttps://doi.org/10.3390/separations10050278openalex-snapshot

An UPLC–ESI–MS/MS Bioanalytical Methodology for the Quantification of Gilteritinib in Human Liver Microsomes: Application to In Vitro and In Silico Metabolic Stability Estimation

inferred← citeshttps://doi.org/10.3390/separations10050302openalex-snapshot

Development of a Fast and Sensitive UPLC–MS/MS Analytical Methodology for Fenebrutinib Estimation in Human Liver Microsomes: In Vitro and In Silico Metabolic Stability Evaluation

inferred← citeshttps://doi.org/10.3390/separations10060330openalex-snapshot

An LC–MS/MS Analytical Method for Quantifying Tepotinib in Human Liver Microsomes: Application to In Vitro and In Silico Metabolic Stability Estimation

inferred← citeshttps://doi.org/10.3390/separations10080450openalex-snapshot

A Fast LC-MS/MS Methodology for Estimating Savolitinib in Human Liver Microsomes: Assessment of Metabolic Stability Using In Vitro Metabolic Incubation and In Silico Software Analysis

inferred← citeshttps://doi.org/10.3390/separations10090472openalex-snapshot

A Sensitive, Green, and Fast LC–MS/MS Analytical Method for the Quantification of Ribociclib: Evaluation of the Metabolic Stability in HLMs

inferred← citeshttps://doi.org/10.34133/csbj.0184openalex-snapshot

Cross-Species Multitask Learning with Molecular and ADME Descriptors for Liver Microsomal Metabolic Stability

inferred← citeshttps://doi.org/10.4018/979-8-3373-6058-4.ch007openalex-snapshot

Molecular Docking and Virtual Screening

inferred← citeshttps://doi.org/10.51435/turkjac.1514896openalex-snapshot

Metabolic stability of a hydrazone derivative: N′-[(4-chlorophenyl)methylidene)]-4-[(4-methylphenyl)sulfonyloxy]benzohydrazide

inferred← citeshttps://doi.org/10.5772/intechopen.99762openalex-snapshot

In vitro Metabolic Stability of Drugs and Applications of LC-MS in Metabolite Profiling

inferred← citeshttps://doi.org/10.58837/chula.the.2019.408openalex-snapshot

In vitro hepatic metabolism of curcumin diethyl disuccinate in different animal species

inferred← citeshttps://doi.org/10.7324/japs.2021.120203openalex-snapshot

New hybrid scaffolds based on ASA/genistein: Synthesis, cytotoxic effect, molecular docking, drug-likeness, and in silico ADME/Tox modeling

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.